Clinical Trials on Advanced Prostate Cancer in Singapore
Total 653 results
-
National University Hospital, SingaporeCompletedHormone-Refractory Prostate CancerSingapore
-
National University Hospital, SingaporeNational University of SingaporeActive, not recruitingProstate Cancer | Metastatic Cancer | Castration-resistant Prostate Cancer | Hormone Sensitive Prostate CancerSingapore
-
Trans Tasman Radiation Oncology GroupBayer; Peter MacCallum Cancer Centre, AustraliaRecruitingAdvanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSAAustralia, Singapore
-
University of ChicagoNational Cancer Institute (NCI)CompletedCastration-resistant Prostate Cancer | Stage IV Prostate CancerSingapore, United States
-
Singapore General HospitalActive, not recruiting
-
National Cancer Centre, SingaporeUnknown
-
National Cancer Centre, SingaporeUnknownProstate CancerSingapore
-
Singapore General HospitalCompletedCancer of the ProstateSingapore
-
InSightecCompletedLocalized Low-Intermediate Risk Prostate CancerUnited Kingdom, Israel, Canada, Italy, Singapore
-
National University Hospital, SingaporeUnknownCancer (Advanced Stage)Singapore
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
SingHealth PolyclinicsCompletedAdvanced Medical Directive, a Legal Document Signed in Advance to State Healthcare PreferencesSingapore
-
Duke-NUS Graduate Medical SchoolNational University Hospital, Singapore; National Cancer Centre, SingaporeUnknownAdvanced CancerSingapore
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Japan, Singapore, Canada, Israel, Switzerland, Australia, United States
-
National University Hospital, SingaporeAdagene IncRecruitingAdvanced Solid Tumor | HER2-negative Breast CancerSingapore
-
National Cancer Centre, SingaporeSingapore General Hospital; Singapore Cancer Society; Genome Institute of Singapore and other collaboratorsRecruitingLocally Advanced Breast Cancer | Early-stage Breast CancerSingapore
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
National Cancer Centre, SingaporeMSD Pharma (Singapore) Pte LtdRecruitingHormone Receptor-Positive HER2-Negative Advanced Breast CancerSingapore
-
Singapore Clinical Research InstituteClinDatrix, Inc.; MicroVAX, LLCUnknownEpithelial Cancers of the Lung, Breast, Ovary, Prostate and ColonSingapore
-
National University Hospital, SingaporeMerck Sharp & Dohme LLC; Adagene IncRecruitingTriple Negative Breast Cancer | Advanced Solid TumorSingapore
-
National Cancer Centre, SingaporeCompletedHER 2 Positive Advanced Gastric CancerSingapore
-
National University Hospital, SingaporeCompleted
-
National University Hospital, SingaporeUnknownAdvanced Solid TumorsSingapore
-
National University Hospital, SingaporeCompleted
-
National University Hospital, SingaporeUnknownLocally Advanced Cervical CancerSingapore
-
Astellas Pharma Singapore Pte. Ltd.CompletedProstate CancerHong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
National University Hospital, SingaporeINTRA-IMMUSG PRIVATE LIMITEDUnknown
-
National Cancer Centre, SingaporeDuke-NUS Graduate Medical SchoolCompletedAdvanced Lung CancerSingapore
-
NanoCarrier Co., Ltd.Orient Europharma Co., Ltd.CompletedLocally Advanced and Metastatic Pancreatic CancerTaiwan, Singapore
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
University College, LondonRecruitingProstate CancerUnited States, Canada, Spain, Finland, Argentina, Australia, Belgium, Brazil, Denmark, France, Germany, Italy, Netherlands, Singapore, United Kingdom
-
National University Hospital, SingaporeUnknownBreast Cancer | Gastric Cancer | Prostate Cancer | Non-small Cell Lung Cancer | Solid TumorsSingapore
-
ExelixisTakeda; Roche-GenentechActive, not recruitingMetastatic Prostate Cancer | Prostate AdenocarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Russian Federation, Singapore, Spain, ... and more
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate CancerHong Kong, Canada, China, Germany, Spain, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Australia, Denmark, France, United States, Singapore, Poland, Malaysia, Turkey, Belgium, Argentina, Thailand, Slovakia, Brazil, Finland, Ita... and more
-
National Cancer Centre, SingaporeFerring Pharmaceuticals; National Medical Research Council (NMRC), Singapore; Duke-NUS Graduate Medical School and other collaboratorsRecruitingNasopharyngeal Cancer | Prostate Cancer | Other CancerSingapore
-
National Cancer Centre, SingaporeINTRA-IMMUSG PRIVATE LIMITEDRecruitingHepatocellular Carcinoma | Gastric Cancer | Advanced Solid TumorSingapore
-
National University Hospital, SingaporeRecruitingMetastatic Solid Malignancies | Advance Solid MalignanciesSingapore
-
National University Hospital, SingaporeUnknownAdvanced Glaucoma | Refractory GlaucomaSingapore
-
National University Hospital, SingaporeUnknownAdvanced Glaucoma | Failed TrabeculectomiesSingapore
-
National Cancer Centre, SingaporeSingapore Translational Cancer Consortium; Genome Institute of Singapore; Cancer...RecruitingNon-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Advanced Solid TumoursSingapore
-
Tan Tock Seng HospitalRecruitingAdvanced Cancer | Hyperactive Delirium | Olanzapine | Haloperidol | End-stage Organ DiseaseSingapore
-
BayerRecruitingMetastatic Castrate Resistant Prostate Cancer (mCRPC)Czechia, France, Hungary, Italy, Poland, Spain, Taiwan, United Kingdom, Korea, Republic of, Singapore, Hong Kong, Australia, Finland, Germany, Israel, Lithuania, Russian Federation, Turkey, Austria
-
BayerCompletedBone Metastases | Hormone Refractory Prostate CancerItaly, Spain, Hong Kong, Canada, United Kingdom, France, Australia, United States, Germany, Brazil, Israel, Netherlands, Norway, Belgium, Sweden, Czech Republic, Poland, Singapore, Slovakia
-
National Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States, Singapore
-
Singapore General HospitalCompletedBenign Prostatic HyperplasiaSingapore